BZBartosz Zięba

Bartosz Zięba

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bartosz Zięba has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Novel Techniques and Emerging Technologies in Chronic Total Occlusion Percutaneous Coronary Intervention: A Structured, Narrative Review

    by Michał Dobrzyński, Paweł Warzyszak, Bartosz ZięBa

    Chronic total occlusions (CTOs) represent one of the most technically demanding areas of percutaneous coronary intervention (PCI). Despite advances in equipment and operator expertise, CTO PCI remains associated with lower procedural success rates and a higher risk of complications than non-CTO PCI. This review summarizes emerging techniques and technologies designed to improve procedural efficiency, safety, and outcomes in contemporary, personalized patient care. Recent innovations span multiple domains of CTO PCI. The minimalistic hybrid approach (MHA) aims to reduce vascular complications by minimizing the number of access sites and the sheath size. Novel perforation management strategies, including the cut balloon technique (CBT) and the condom technique, offer simple, low-cost options for distal vessel sealing, supported so far only by small series and technical reports. Advanced re-entry methods, such as tip-detection, antegrade dissection and re-entry (TD-ADR), integrate intravascular ultrasound (IVUS) to enhance precision. HydroDynamic contrast recanalization (HDR) revisits hydraulic dissection with a controlled, microcatheter-based contrast strategy whose safety profile remains to be established. The microcatheter anchor technique (MAT) has been proposed to facilitate retrograde CTO PCI in post-CABG anatomy. New plaque-modifying strategies, including RODIN-CUT and ORCAS, leverage high-pressure cutting balloon inflations under real-time IVUS guidance. Additional technologies, such as Plasmawire™, Shockwave Javelin®, and Hertz Contact intravascular lithotripsy (IVL), may expand the armamentarium for crossing and modifying complex CTO lesions, although CTO-specific clinical data are very limited (for Javelin, a 20-patient first-in-human coronary series). CT coronary angiography (CTCA) continues to improve pre-procedural planning, while drug-coated balloons (DCBs) show promise in selected de novo CTO lesions, although the evidence remains limited to retrospective series. Taken together, this rapid pace of innovation is steadily widening the procedural toolkit available for CTO PCI and may improve outcomes. Evidence for most of these techniques comes from case reports, small single-center series, and early-phase single-arm studies. It suggests feasibility in selected patients, but safety data are limited, and some reports signal concerns, including tamponade after the cut balloon technique and a higher perforation rate in a registry of the Carlino technique. The place of these techniques in routine practice will become clear only once larger, multicenter trials are completed.

  • Open Access

    Embolization of Perforated Coronary Artery with a Fragment of Balloon Catheter (Cut Balloon Technique)—Multicenter Study

    by Grzegorz Sobieszek, Bartosz Zięba, Wojciech Dworzański, Rafał Celiński, Umberto Barbero, Maksymilian P. Opolski

    Background: Iatrogenic distal coronary artery perforation can be a life-threatening complication. While there are different dedicated devices for the embolization of distal perforations, there are scarce data about the embolization using the fragmented balloon catheter, the so-called cut balloon technique (CBT). Methods: We included consecutive patients with distal coronary perforations treated with CBT in four cardiac centers between 2017 and 2023. Clinical, angiographic and procedural characteristics as well as in-hospital outcomes were recorded. Results: Twenty-six patients (68% men, mean age: 71 ± 10.6 years) with 25 distal coronary perforations and one septal collateral perforation were included. Eleven patients (42%) had elective percutaneous coronary intervention, while fifteen patients (58%) were treated for acute coronary syndrome. The site of perforation was most frequently distributed in the left anterior descending artery (40%), followed by the circumflex artery (28%) and right coronary artery (24%). The diameter of balloons for CBT ranged from 1.5 to 4.0 mm, with most balloons (76%) being either 2.0 or 2.5 mm in diameter. Most balloons (88%) were previously used for lesion predilatation. The numbers of cut balloons needed to seal the perforation were 1, 2 and ≥3 in 48%, 20% and 32% of cases, respectively. The in-hospital prognosis was favorable, with cardiac tamponade requiring pericardiocentesis in only four (16%) patients. Neither emergency surgery nor cardiac death occurred. Conclusions: CBT is a safe, efficient and easy-to-implement technique for the embolization of coronary perforations. Most distal coronary perforations can be sealed with one or two fragments of cut balloons, obviating the need for additional devices.


  • Open Access

    Untargeted metabolomics towards understanding molecular mechanisms of pulmonary arterial hypertension

    by R Wawrzyniak, A Dabrowska-Kugacka, S Macioszek, I Gockowska, M Biesemans, A Furga, B Zieba, E Lewicka, M Markuszewski

    Background: Pulmonary hypertension constitutes a rare disease characterized by a severe development and a high risk of premature death. One of its main clinical types is pulmonary arterial hypertension (PAH), in which the highest percentage of patients are affected by idiopathic PAH. The pathogenesis of this disease has not completely been discovered and elucidated so far, and non-specific clinical symptoms make the diagnosis of PAH a serious problem. Currently, PAH is confirmed with invasive examination based on right heart catheterization. Purpose: The main aim of the study was to evaluate and compare both plasma and urine fingerprints of PAH patients and control group with the use of an untargeted metabolomics approach. The study also focused on correlation analysis between the observed metabolic changes and the clinical parameters to select specific indicators of PAH disease. Methods: An untargeted metabolomics approach was applied to the plasma and urine samples with the use of gas chromatography coupled to triple quadrupole mass spectrometry (GC-QqQ/MS) and advanced statistical tests were applied to evaluate the potential metabolic indicators of PAH. The PAH patients (n=40) and healthy controls (n=39) were matched for age, sex, BMI and included in the study. The obtained raw datasets were properly processed (data deconvolution, signal correction using QCSVR method and PQN normalization) and subsequently subjected to uni- and multivariate statistical tests (Student's t-test, Welch's test, U Mann-Whitney test, PCA and OPLS-DA). The identification of the statistically significant metabolites was performed using universal libraries, such as: Fiehn's and NIST11. Results: The statistically significant metabolites (n=10 and 11 for urine and plasma samples, respectively)originate from various biochemical pathways associated with the carbohydrate, amino acid, lipid, fatty acid and pyrimidine metabolism. The metabolic changes observed in the urine samples of PAH patients (compared to the control group) included different concentrations in: threonic acid, hippuric acid, acetic acid, sorbitol, butanoic acid and propionic acid. The metabolic alterations in the plasma samples covered changes in the levels of valine, leucine, lactic acid, hydroxybutanoic acid, nonanoic acid, cholesterol and octadecanoic acid. Metabolites representing the highest correlation with mean pulmonary arterial pressure include, for instance: propionic acid (r=0.85), valine (r=0.75) and lactic acid (r=0.63) Conclusions: The observed metabolic changes are related to various biological processes that are disturbed in the course of PAH, namely: proliferation of pulmonary vascular cells or the functions of cardiomyocytes and the right ventricle of the heart. The obtained results confirmed the potential of a metabolomics approach to uncover and explain the underlying molecular mechanisms of PAH. Funding Acknowledgement: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Science and High Education of Poland


  • Balloon Fragment Technique Used to Close Distal Coronary Vessel Perforation

    by Grzegorz Sobieszek, Bartosz Zięba

    We present a method of treating distal perforation that involves embolization of a perforated vessel with a cut part of a balloon catheter. from Journal of Invasive Cardiology.


  • Open Access

    Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease

    by Elżbieta Kimak, Bartosz Zięba, Dariusz Duma, Janusz Solski

    Myeloperoxidase (MPO) impairing endothelial functions. We investigated whether increasing concentration of myeloperoxidase (MPO) and inflammatory markers induce progression and incident acute coronary syndrome (ACS) in stable coronary artery disease (SCAD) patients. Therefore, the concentration of MPO, lipids, lipoproteins (apo(apolipoprotein) AI, apoB, lipoprotein associated phospholipase A2 (LpPLA2) level), inflammatory markers (high sensitivity C-reactive protein (hsCRP), tumor necrosis factor-α (TNF-α), interleukine-6 (IL-6) concentration) were examined. This study concerned 67 SCAD patients divided into groups: all patients, patients with MPO < 200 ng/ml, MPO 200–300 ng/ml, MPO > 300 ng/ml concentration and 15 controls. ApoAI, apoB and hsCRP levels were examined using the immunonephelometric method, and MPO, LpPLA2, IL-6, TNF-α concentration was performed by using Quantikine ELISA kit R&D Systems. In the all patients, and in group with MPO 200–300 ng/ml TC, LDL-C, nonHDL-C, LpPLA2 concentration and TC/HDL-C, LDL-C/HDL-C ratios were insignificant, and significantly higher concentration of TG, apoB, MPO, inflammatory markers and TG/HDL-C, MPO/apoAI, MPO/HDL-C ratios but HDL-C, apoAI level and HDL-C/apoAI ratio were significantly reduced. In the group of patients with MPO < 200 ng/ml, level of TC, LDL-C, nonHDL-C, apoAI, apoAII, LpPLA2 and MPO and LDL-C/HDL-C ratio were in-significant, HDL-C was decreased but apoB, TG, inflammatory markers, apoB/apoAI, TG/HDL-C, MPO/apoAI, MPO/HDL-C ratio were significantly increased. In the group of patients with MPO > 300 ng/ml concentration of TC, LDL-C, nonHDL-C, apoAII, LpPLA2 and LDL-C/HDL-C ratios were not significant, but HDL-C and apoAI concentrations were significantly decreased. The concentrations of TG, apoB, MPO and inflammatory markers and TG/HDL-C, MPO/apoAI, MPO/HDL-C ratios were significantly increased compared to the controls. The apoAI concentration was significantly decreased and the concentration of MPO and hsCRP as well as MPO/apoAI and MPO/HDL-C ratios were significantly higher as compared to the group of patients with MPO < 200 ng/ml. Spearman’s correlation test showed a positive correlation between MPO concentration and MPO/apoAI and MPO/HDL-C ratios in all patients and MPO < 200 ng/ml, MPO 200–300 ng/ml. The patients with MPO > 300 ng/ml showed a positive correlation between the concentration of MPO and the level of hsCRP and IL-6, and a negative correlation between MPO/apoAI ratio and the concentration of HDL-C, apoAI and apoAII. The results suggest that moderate dyslipidemia and dyslipoproteinemia deepening of inflammation, and inflammation slowly induce increase MPO concentration which decrease apoAI and HDL-C level and disturb HDLs function. The increasing MPO level and MPO/HDL-C, MPO/apoAI ratios can differentiate the SCAD patients at the risk of acute coronary syndrome (ACAD) and stroke.